Mirdametinib approved to treat plexiform neurofibromas in children, adolescents, and adults with neurofibromatosis type 1
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 December 2025) approved the medicine mirdametinib (Ezmekly) for…